中国成都9-45岁女性人乳头瘤病毒疫苗接种覆盖率的变化趋势:2017至2023年的洞察
研究基于四川省免疫规划信息系统数据,描述2017至2023年成都9-45岁女性HPV疫苗首剂与全程接种覆盖率,并按年龄、地区、疫苗类型分层;采用中断时间序列分段回归评估2021年补贴项目对13-14岁女孩接种率的影响。2023年累积首剂覆盖率为34.17%、全程为24.40%,13-14岁女孩接种率较项目前显著上升。
要点
- 2017至2023年成都9-45岁女性HPV疫苗首剂和全程覆盖率在各年龄组、地区及疫苗类型均呈显著上升趋势。
- 2023年累积首剂覆盖率为34.17%,全程覆盖率为24.40%。
- 13-14岁女孩首剂和全程接种率较项目前显著升高(β=1.899,p=0.002;β=4.859,p<0.001)。
核心结论
- 成都实施HPV疫苗接种项目后,13-14岁女孩接种率显著上升,但9-45岁女性总体接种率仍相对较低,尤其在某些亚人群中。
研究设计与样本
- 数据来源于四川省免疫规划信息系统,对2017至2023年成都9-45岁女性HPV疫苗接种数据进行描述性分析,并采用中断时间序列分段回归模型评估13-14岁女孩接种率变化。
主要发现
- 2017至2023年,成都9-45岁女性HPV疫苗首剂和全程接种覆盖率在各年龄组、地理区域和疫苗类型均呈显著上升趋势。
- 2023年累积首剂接种覆盖率为34.17%,全程接种覆盖率为24.40%。
- 13-14岁女孩首剂接种率较项目前变化β=1.899(p=0.002),全程接种率变化β=4.859(p<0.001)。
关键数值与推荐
- 2021年成都实施针对13-14岁女孩的补贴HPV疫苗接种项目。
- 2023年累积首剂覆盖率为34.17%,全程覆盖率为24.40%。
- 13-14岁女孩首剂接种率变化β=1.899(p=0.002),全程接种率变化β=4.859(p<0.001)。
临床怎么用
- 作者认为,为提升总体接种率,策略重点应包括针对覆盖不足亚人群的干预、扩大试点项目以及更强政治承诺将HPV疫苗纳入国家免疫规划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chengdu, China, is facing an increasing burden of cervical cancer. Although human papillomavirus (HPV) vaccines have been introduced in China since 2016, vaccination coverage remains suboptimal, and data on regional disparities are limited. In 2021, Chengdu implemented a subsidized HPV vaccination program targeting girls aged 13-14 years. This study aims to evaluate HPV vaccination coverage among females aged 9-45 years in Chengdu from 2017 to 2023, stratified by age group, geographic area, and vaccine type, and to examine changes in vaccination coverage among girls aged 13-14 years following the city's enrollment in the pilot subsidy program. METHODS: HPV vaccination data were sourced from the Sichuan Provincial Immunization Information System. Descriptive analyses assessed annual and cumulative vaccination coverage from 2017 to 2023 among females aged 9-45 years in Chengdu. An interrupted time series (ITS) analysis using a segmented regression model (SRM) was conducted to quantify changes in vaccination rates following program implementation among girls aged 13-14 years. RESULTS: From 2017 to 2023, first- and full-dose HPV vaccination coverage among females aged 9-45 years in Chengdu showed significant upward trends across age groups, geographic areas, and vaccine types. By 2023, cumulative first-dose coverage reached 34.17 %, with full-dose coverage at 24.40 %. Notably, vaccination rates for girls aged 13-14 years exhibited markedly higher first- and full-dose coverage compared to pre-program levels (β = 1.899, p-value = 0.002; β = 4.859, p-value <0.001, respectively). CONCLUSIONS: Following the HPV vaccination program in Chengdu, the vaccination rate for girls aged 13-14 years significantly increased. However, the overall vaccination rate for women aged 9-45 years remains relatively low, particularly among certain subpopulations. To enhance overall vaccination rates, strategic priorities should include targeted interventions for subpopulations with suboptimal coverage, expansion of pilot programs, and stronger political commitment to integrating the HPV vaccine into the National Immunization Program.
引用
- Li J, Zhao D, Zi T, et al. Evolving trends in HPV vaccination coverage among women aged 9-45 in Chengdu, China: insights from 2017 to 2023. Vaccine. 2025. PMID: 40780092. doi:10.1016/j.vaccine.2025.127579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。